Elite Pharmaceuticals, Inc. Operating Lease, Liability, Current
Elite Pharmaceuticals, Inc. (ELTP) had Operating Lease, Liability, Current of $553.53 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Leases › Assets and Liabilities, Lessee
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-13
- 2026-06-30: Operating Lease, Liability, Current $553.53K.
- 2026-03-31: Operating Lease, Liability, Current $536.43K.
- 2025-12-31: Operating Lease, Liability, Current $519.74K.
- 2025-09-30: Operating Lease, Liability, Current $503.51K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $553.53K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $536.43K 10-Q · filed 2026-08-13 |
| 2025-12-31 | $519.74K 10-Q · filed 2026-02-17 |
| 2025-09-30 | $503.51K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $487.76K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $472.39K 10-K · filed 2026-06-29 |
| 2024-12-31 | $457.40K 10-Q · filed 2025-02-13 |
| 2024-09-30 | $422.32K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $416.76K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $411.42K 10-K · filed 2025-06-30 |
| 2023-12-31 | $26.23K 10-Q · filed 2024-02-14 |
| 2023-09-30 | $2.16K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $8.59K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $14.91K 10-K · filed 2024-07-01 |
| 2022-12-31 | $21.15K 10-Q · filed 2023-02-14 |
| 2022-09-30 | $25.07K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $207.37K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $202.95K 10-K · filed 2023-06-29 |
| 2021-12-31 | $153.81K 10-Q · filed 2022-02-14 |
| 2021-09-30 | $209.69K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $205.82K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $188.09K 10-K · filed 2022-06-29 |
| 2020-12-31 | $221.17K 10-Q · filed 2021-02-16 |
| 2020-09-30 | $216.77K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $212.45K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $208.18K 10-K · filed 2021-06-14 |
| 2019-12-31 | $203.98K 10-Q · filed 2020-02-10 |
| 2019-09-30 | $199.87K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $195.81K 10-Q · filed 2019-08-09 |
| 2019-04-02 | $375.29K 10-Q · filed 2019-08-09 |